Assaf Oron insider trades: BiomX (PHGE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Assaf reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 29, 2023 | PHGE | ↓ Sell | 10,914 | $0.37 | $4K | Direct | Dec 1, 2023 (2d) |
| May 22, 2023 | PHGE | ↑ Buy | 3,192 | $0.27 | $872 | Direct | May 24, 2023 (2d) |
| May 19, 2023 | PHGE | ↑ Buy | 7,722 | $0.28 | $2K | Direct | May 22, 2023 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PHGE insiders
Open-market trades in the last 12 months
About Assaf Oron's insider trades
Assaf Oron is Chief Business Officer at BiomX (PHGE). Since May 19, 2023, Assaf has reported 2 open-market purchases worth $3K and 1 sale worth $4K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PHGE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.